Kumar, M, Bajpai, R ORCID: https://orcid.org/0000-0002-1227-2703, Shaik, AR, Srivastava, S and Vohora, D (2020) Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis. European Journal of Clinical Pharmacology.

[img] Text
e.Proofing.pdf - Accepted Version
Restricted to Repository staff only until 21 June 2021.
Available under License Creative Commons Attribution Non-commercial.

Download (1MB)

Abstract

Purpose In the past few years, several fracture-related events have been reported with chronic use of selective serotonin reuptake inhibitors (SSRIs) throughout the globe. Hence, an updated systematic review and meta-analysis was necessary to ascertain the risk involved. The present work evaluated the association of SSRIs with the risk of fracture in adults. Methods We systematically searched PubMed, Cochrane library, and Google Scholar for observational studies on the same from inception to April 2019. Screening, data extraction, and risk of bias assessment were conducted independently by 2 authors. Results We assessed 69 studies out of which 37 (14 case-control, 23 cohorts) were included. Our results showed that SSRIs were significantly associated with an increased fracture risk (relative risk of 1.62, 95% CI 1.52–1.73; P < 0.000; I2 = 90.8%). The relative risk values for case-control and cohort studies were found to be 1.80 (95% CI 1.58–2.03; P < 0.000; I2 = 93.2%) and 1.51 (95% CI 1.39–1.64; P < 0.000; I2 = 88.0%) respectively. Subgroup analysis showed that association of risk of fracture persisted regardless of geographical location, study design, risk factors, defined daily dose, SSRI use duration, site of the fracture, period of study and after adjusting for depression, physical activity, gender, and age group. The sensitivity analysis data shows that the studies adjusted for bone mineral density and osteoporosis show lesser fracture risk. Conclusion Our findings suggests that SSRIs may be associated with an increased fracture risk; hence, bone health should be taken into consideration while prescribing this class of drugs.

Item Type: Article
Additional Information: The final version of this accepted manuscript can be accessed online at https://link.springer.com/article/10.1007/s00228-020-02893-1#Abs1
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
Divisions: Faculty of Medicine and Health Sciences > School of Primary, Community and Social Care
Depositing User: Symplectic
Date Deposited: 01 Jul 2020 07:35
Last Modified: 01 Jul 2020 07:35
URI: https://eprints.keele.ac.uk/id/eprint/8267

Actions (login required)

View Item View Item